Open AccessClinical case: criteria for differential diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy
Author(s) -
Nataliya Kravchuk
Publication year - 2015
Publication title -
shìdno-êvropejsʹkij nevrologìčnij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2663-8444
pISSN - 2411-5797
DOI - 10.33444/2411-5797.2015.4(4).48-52
Subject(s) - chronic inflammatory demyelinating polyneuropathy , medicine , polyradiculoneuropathy , guillain barre syndrome , disease , myelin , polyneuropathy , differential diagnosis , peripheral , gastroenterology , immunology , pediatrics , pathology , central nervous system , antibody
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disease that is characterized by inflammation of nerve roots and peripheral nerves, nerve destruction of the myelin sheath, the appearance of slowly-progressive symmetric symptoms, motor and sensory disorders. CIDPsometimes considered a chronic form of acute inflammatory demyelinating polyneuropathy (АIDP) - Guillain Barré syndrome (GBS). In contrast to GBS, most patients do not mark HDPNP previous viral or infectious disease. CIDP is subacute-progressive disease that clinically takes 3-4 weeks, then usually comes plateau phase, which changes the phase of gradual regression of symptoms. CIDP can affect any age group. CIDP registered twice as often in men. The average age of onset of the disease is 50 years. CIDP prevalence is estimated at about 5-7 cases per 100 thousand people.